ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

People

Merck KGaA appoints Belén Garijo its CEO

by Megha Satyanarayana
October 2, 2020 | APPEARED IN VOLUME 98, ISSUE 38

 

09838-buscon15-garijo.jpg
Credit: Merck KGaA
Belen Garijo

Merck KGaA has named Belén Garijo its CEO starting May 1, 2021. Garijo will become one of a handful of women leading major drug companies, including Emma Walmsley of GlaxoSmithKline, Deborah Dunsire at Lundbeck Pharmaceuticals, and Reshma Kewalramani of Vertex Pharmaceuticals. Currently deputy CEO, Garijo will succeed Stefan Oschmann. Garijo is a trained physician.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment